Увійти

Готові списки джерел за темами / Mesothelin targeted cancer immunotherapy / Книги

Щоб переглянути інші типи публікацій з цієї теми, перейдіть за посиланням: Mesothelin targeted cancer immunotherapy.

Книги з теми "Mesothelin targeted cancer immunotherapy"

Автор: Grafiati

Опубліковано: 11 березня 2023

Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями

Оберіть тип джерела:

Ознайомтеся з топ-30 книг для дослідження на тему "Mesothelin targeted cancer immunotherapy".

Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.

Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.

Переглядайте книги для різних дисциплін та оформлюйте правильно вашу бібліографію.

1

Yan, Cui, Li Shulin, and SpringerLink (Online service), eds. Targeted Cancer Immune Therapy. New York, NY: Springer-Verlag New York, 2009.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

2

N, Syrigos Konstantinos, and Harrington Kevin J. 1958-, eds. Targeted therapy for cancer. Oxford: Oxford University Press, 2003.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

3

Anderson, Kenneth C., Razelle Kurzrock, and Apostolia-Maria Tsimberidou. Targeted therapy in translational cancer research. Hoboken, New Jersey: John Wiley & Sons, Inc., 2016.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

4

Alharbi, Yousef, Manish S. Patankar, and Rebecca J. Whelan. Antibody-Based Therapy for Ovarian Cancer. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190248208.003.0006.

Повний текст джерела

Анотація:

With their role in connecting disease-associated antigens to the cellular immune response, antibodies hold considerable promise as therapeutic agents. This chapter discusses three classes of therapeutic antibodies that have been developed for use in ovarian cancer therapy. The first includes antibodies selected against tumor-associated antigens such as MUC16/CA125, mesothelin, epithelial cell adhesion molecule, and folate receptor α‎. Antibodies in the second class target proteins such as CTLA-4 and PD1 that act as immune response checkpoint receptors. The third class of antibodies target secreted factors that promote tumor growth: targets in this class include vascular endothelial growth factor, cytokines, and chemokines. The development of each of these is described. The chapter also discusses the complications presented by soluble antigens, which serve to limit the applicability of antigens (such as MUC16/CA125) that are both cell-surface associated and circulating and the prospects for the combination of antibody-based immunotherapy and chemotherapy.

Стилі APA, Harvard, Vancouver, ISO та ін.

5

Williams, William Valentine, Karen Anderson, David B. Weiner, and Cara Haymaker, eds. Targeted Immunotherapy for Cancer. Frontiers Media SA, 2022. http://dx.doi.org/10.3389/978-2-88976-074-9.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

6

Li, Shulin, Yan Cui, and Joseph Lustgarten. Targeted Cancer Immune Therapy. Springer New York, 2016.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

7

Treating Cancer with Immunotherapy and Targeted Therapy. Mercury Learning & Information, 2019.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

8

Olle, David A. Treating Cancer with Immunotherapy and Targeted Therapy. Mercury Learning & Information, 2022.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

9

Olle, David A. Treating Cancer with Immunotherapy and Targeted Therapy. Mercury Learning & Information, 2022.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

10

Karp, Daniel D., Gerald S. Falchook MD MS, and Joann Lim. Handbook of Targeted Cancer Therapy and Immunotherapy. LWW, 2018.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

11

Karp, Daniel D., Joann Lim, and Gerald S. Falchook. Handbook of Targeted Cancer Therapy and Immunotherapy. Lippincott Williams & Wilkins, 2022.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

12

Olle, David A. Treating Cancer with Immunotherapy and Targeted Therapy. Mercury Learning & Information, 2022.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

13

Handbook of Targeted Cancer Therapy and Immunotherapy: Gastrointestinal Cancer. Lippincott Williams & Wilkins, 2021.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

14

Targeted therapies in oncology. New York: Informa Healthcare, 2007.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

15

Resistance to Immunotherapeutic Antibodies in Cancer Resistance to Targeted AntiCancer Therapeutics. Springer-Verlag New York Inc., 2013.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

16

Markman, Maurie, Kenneth C. Anderson, Razelle Kurzrock, Apostolia-Maria Tsimberidou, and Robert C. Bast. Targeted Therapy in Translational Cancer Research. Wiley & Sons, Incorporated, John, 2015.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

17

Markman, Maurie, Kenneth C. Anderson, Razelle Kurzrock, Bast Robert C. Jr, and Apostolia-Maria Tsimberidou. Targeted Therapy in Translational Cancer Research. Wiley & Sons, Incorporated, John, 2015.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

18

Markman, Maurie, Kenneth C. Anderson, Razelle Kurzrock, Bast Robert C. Jr, and Apostolia-Maria Tsimberidou. Targeted Therapy in Translational Cancer Research. Wiley & Sons, Limited, John, 2015.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

19

Targeted Therapies in Oncology. CRC Press, 2013.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

20

Giaccone, Giuseppe, and Jean-Charles Soria. Targeted Therapies in Oncology. Taylor & Francis Group, 2019.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

21

Giaccone, Giuseppe, and Jean-Charles Soria. Targeted Therapies in Oncology. Taylor & Francis Group, 2013.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

22

Giaccone, Giuseppe, and Jean-Charles Soria. Targeted Therapies in Oncology. Taylor & Francis Group, 2007.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

23

Giaccone, Giuseppe, and Jean-Charles Soria. Targeted Therapies in Oncology. Taylor & Francis Group, 2013.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

24

(Editor), Giuseppe Giaccone, and Jean-Charles Soria (Editor), eds. Targeted Therapies in Oncology. Informa Healthcare, 2007.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

25

Jiang, Tao, Zhu Bo, Shengxiang Ren, and Tetsuya Mitsudomi, eds. Multi-dimensional Biomarkers and Resistance Mechanism of Targeted Therapy and Immunotherapy in Lung Cancer. Frontiers Media SA, 2022. http://dx.doi.org/10.3389/978-2-88974-265-3.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

26

Melanoma Emerging Cancer Therapeutics. Demos Medical Publishing, 2012.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

27

Targeted Radionuclide Tumor Therapy Biological Aspects. Springer, 2008.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

28

Aljabali, Alaa A., and Kaushik Pal, eds. Bionanotechnology: Next-Generation Therapeutic Tools. BENTHAM SCIENCE PUBLISHERS, 2022. http://dx.doi.org/10.2174/97898150512781220101.

Повний текст джерела

Анотація:

Nanoscale technologies are crucial for the characterization and fabrication of biomaterials that are useful in targeted drug delivery systems. New materials enable the delivery of therapeutic agents to specific tissues and cells in order to treat a range of diseases. Bionanotechnology: Next-Generation Therapeutic Tools provides a quick overview of the use of nanomaterials in modern drug delivery and targeted drug therapy systems. The book starts with an overview of nanomaterial toxicity with subsequent chapters detailing their applications in nanomedicine. Concepts such as immunotherapy, cancer theranostics, molecular imaging, aptamers and viral nanoparticles are highlighted in specific chapters. The simplified presentation along with scientific references makes this book ideal for pharmacology and biomedical engineering scholars and life science readers.

Стилі APA, Harvard, Vancouver, ISO та ін.

29

Fancourt, Daisy. Fact file 7: Oncology. Oxford University Press, 2017. http://dx.doi.org/10.1093/oso/9780198792079.003.0020.

Повний текст джерела

Анотація:

Oncology is a branch of medicine focusing on the prevention, diagnosis, and treatment of cancers; one of the leading causes of death in the world. Early records of cancer have been found in fossils from mummies in ancient Egypt and are discussed in some ancient manuscripts, attesting to the long history of the condition. Oncology teams often encompass medical oncologists (who can specialize in chemotherapy, immunotherapy, hormonal therapy, and targeted therapy), surgical oncologists, radiation oncologists, and doctors with specialities in the organs affected....

Стилі APA, Harvard, Vancouver, ISO та ін.

30

Cassidy, Jim, Donald Bissett, Roy A. J. Spence OBE, Miranda Payne, Gareth Morris-Stiff, and Madhumita Bhattacharyya. Gynaecological cancers. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199689842.003.0020_update_001.

Повний текст джерела

Анотація:

Genitourinary cancers examines the malignancies arising in the kidney, ureter, bladder, prostate, testis, and penis. Renal cancer has high propensity for systemic spread, largely mediated by overexpression of vascular endothelial growth factor (VEGF). Treatments include surgery, immunotherapy, and targeted therapy. Wilms tumour, a childhood malignancy of the kidney, warrants specialist paediatric oncology management to provide expertise in its unique pathology, staging, and treatment, often with surgery and chemotherapy. Cancer of the bladder and ureters, another tobacco related cancer, may present as either superficial or invasive disease. The former is managed by transurethral resection and intravesical therapy. The latter may require radical surgery, preoperative chemotherapy, or radiotherapy. Prostate cancer, the commonest male cancer, is an androgen dependent malignancy. It has attracted controversy with regards to PSA screening, and potential over treatment with radical prostatectomy. Division into low, intermediate, and high risk disease according to tumour grade, stage, and PSA helps in deciding best treatment, antiandrogen therapy for metastatic disease, radiotherapy and adjuvant hormone therapy for locally advanced disease, either surgery or radiotherapy for early intermediate risk disease, and active monitoring for low risk cases. Testicular cancer divides according to pathology into seminoma, nonseminomatous germ cell tumours (NSGCT), and mixed tumours, the latter two frequently producing tumour markers, alpha-fetoprotein (AFP) and/or human chorionic gonadotrophin (HCG). Stage I disease is managed by inguinal orchidectomy and surveillance or adjuvant chemotherapy. More advanced disease is managed by chemotherapy, with high probability of cure in the majority. Penile cancer, often HPV related, can be excised when it presents early, but delay in presentation may lead to regional and systemic spread with poor prognosis.

Стилі APA, Harvard, Vancouver, ISO та ін.

Ми пропонуємо знижки на всі преміум-плани для авторів, чиї праці увійшли до тематичних добірок літератури. Зв'яжіться з нами, щоб отримати унікальний промокод!